{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:16:00Z","timestamp":1793754960953,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Japanese Society of Nephrology and Pharmacotherapy","award":["2023-1"],"award-info":[{"award-number":["2023-1"]}],"id":[{"id":"https:\/\/ror.org\/014c6rd81","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K23264"],"award-info":[{"award-number":["JP24K23264"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triple Whammy (TW) therapy, a combination of renin-angiotensin system inhibitors (RASIs), diuretics, and non-steroidal anti-inflammatory drugs (NSAIDs), is associated with an increased risk of acute kidney injury (AKI). However, there is no consensus regarding the impact of NSAID type on the risk of AKI. Therefore, in this study, we evaluated the incidence and risk of NSAID-induced AKI in patients taking concomitant RASIs and diuretics, focusing on NSAID type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an observational retrospective cohort study using a Japanese medical claims database. In the cohort analysis, 41,904 patients who received concomitant RASIs, diuretics, and newly added NSAIDs between April 2020 and March 2021 were included to estimate AKI incidence. In the case-crossover analysis, 2,909 patients who developed AKI while on RASIs and diuretics were analyzed to assess the short-term risk associated with NSAID use. Incidence rates were calculated using the person-year method. Conditional logistic regression was used to estimate adjusted odds ratios (aOR), accounting for surgical procedures and concomitant AKI risk drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 41,904 patients, 54 developed AKI (20.0 [95% CI: 14.8\u201325.6] per 1,000 person-years). The incidence rate ratio of TW to RASIs and diuretics without NSAIDs was 2.08 [95% CI: 1.58\u20132.74]. Case-crossover analysis showed an aOR of 1.44 [95% CI: 1.17\u20131.78] for AKI associated with NSAID use. No substantial differences were observed between COX-2 selective and nonselective NSAIDs (aOR: 0.99 [95% CI: 0.66\u20131.50]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The addition of NSAIDs to RASIs and diuretics significantly increased AKI risk, emphasizing the need for careful monitoring regardless of the NSAID type.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-025-00485-8","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T09:36:29Z","timestamp":1755509789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["NSAID-Induced acute kidney injury risk in patients on renin-angiotensin system inhibitors and diuretics: nationwide cohort study"],"prefix":"10.1186","volume":"11","author":[{"given":"Yuki","family":"Kunitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Hira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"485_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5694\/j.1326-5377.2000.tb125548.x","volume":"172","author":"MC Thomas","year":"2000","unstructured":"Thomas MC, Diuretics. ACE inhibitors and NSAIDs\u2013the triple whammy. Med J Aust. 2000;172:184\u20135.","journal-title":"Med J Aust"},{"key":"485_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.0306-5251.2004.2188.x","volume":"59","author":"KL Katarzyna","year":"2005","unstructured":"Katarzyna KL, Gillian MS. Drug combinations and impaired renal function \u2013 the \u2018triple whammy\u2019. Br J Clin Pharmacol. 2005;59:239\u201343.","journal-title":"Br J Clin Pharmacol"},{"key":"485_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5694\/j.1326-5377.2000.tb125642.x","volume":"173","author":"IW Boyd","year":"2000","unstructured":"Boyd IW, Mathew TH, Thomas MC. COX-2 inhibitors and renal failure: the triple whammy revisited. Med J Aust. 2000;173:274.","journal-title":"Med J Aust"},{"key":"485_CR4","doi-asserted-by":"publisher","first-page":"e8525","DOI":"10.1136\/bmj.e8525","volume":"346","author":"F Lapi","year":"2013","unstructured":"Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525.","journal-title":"BMJ"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1248\/yakushi.19-00096","volume":"139","author":"Y Kunitsu","year":"2019","unstructured":"Kunitsu Y, Isono T, Hira D, Terada T. Chronic effects on kidney function by triple whammy (Combination of Renin and angiotensin type inhibitor, diuretic drug and nonsteroidal Anti-inflammatory drug). Yakugaku Zasshi. 2019;139:1457\u201362.","journal-title":"Yakugaku Zasshi"},{"key":"485_CR6","doi-asserted-by":"publisher","first-page":"e0263682","DOI":"10.1371\/journal.pone.0263682","volume":"17","author":"Y Kunitsu","year":"2022","unstructured":"Kunitsu Y, Hira D, Morikochi A, Ueda T, Isono T, Morita S-Y, et al. Time until onset of acute kidney injury by combination therapy with triple whammy drugs obtained from Japanese adverse drug event report database. PLoS ONE. 2022;17:e0263682.","journal-title":"PLoS ONE"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nefroe.2015.05.010","volume":"35","author":"RMG Camin","year":"2015","unstructured":"Camin RMG, Cols M, Chevarria JL, Garc\u00eda Osuna R, Carreras M, Lisbona JM, et al. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: the triple whammy. Nefrolog\u00eda (English Edition). 2015;35:197\u2013206.","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"485_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-133-1-200007040-00002","volume":"133","author":"SK Swan","year":"2000","unstructured":"Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, et al. Effect of cyclooxygenase-2 Inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Ann Intern Med. 2000;133:1\u20139.","journal-title":"Ann Intern Med"},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1093\/eurheartj\/ehx508","volume":"38","author":"F Ruschitzka","year":"2017","unstructured":"Ruschitzka F, Borer JS, Krum H, Flammer AJ, Yeomans ND, Libby P, et al. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective randomized evaluation of celecoxib integrated safety versus ibuprofen or Naproxen ambulatory blood pressure Measurement) trial. Eur Heart J. 2017;38:3282\u201392.","journal-title":"Eur Heart J"},{"key":"485_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ehjcvp\/pvac015","volume":"8","author":"S Obeid","year":"2022","unstructured":"Obeid S, Libby P, Husni E, Wang Q, Wisniewski LM, Davey DA, et al. Cardiorenal risk of celecoxib compared with Naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial. Eur Heart J Cardiovasc Pharmacother. 2022;8:611\u201321.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans ND, Solomon DH, L\u00fcscher TF, Libby P, Husni ME, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375:2519\u201329.","journal-title":"N Engl J Med"},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/2047487319848105","volume":"27","author":"A Cabassi","year":"2020","unstructured":"Cabassi A, Tedeschi S, Perlini S, Verzicco I, Volpi R, Gonzi G, et al. Non-steroidal anti-inflammatory drug effects on renal and cardiovascular function: from physiology to clinical practice. Eur J Prev Cardiol. 2020;27:850\u201367.","journal-title":"Eur J Prev Cardiol"},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3390\/ph3072291","volume":"3","author":"WH H\u00f6rl","year":"2010","unstructured":"H\u00f6rl WH. Nonsteroidal Anti-Inflammatory drugs and the kidney. Pharmaceuticals. 2010;3:2291\u2013321.","journal-title":"Pharmaceuticals"},{"key":"485_CR14","doi-asserted-by":"crossref","unstructured":"Sato S, Sasabuchi Y, Okada A, Yasunaga H. Do Orally Disintegrating Tablets Facilitate Medical Adherence and Clinical Outcomes in Patients with Post-stroke Dysphagia? Dysphagia. 2024;40:381\u20137.","DOI":"10.1007\/s00455-024-10737-8"},{"key":"485_CR15","first-page":"190","volume":"5","author":"A Okada","year":"2022","unstructured":"Okada A, Yasunaga H. Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, Middle-aged, and elderly people. Jma J. 2022;5:190\u20138.","journal-title":"Jma J"},{"key":"485_CR16","doi-asserted-by":"crossref","unstructured":"Lim CC, Tan NC, Teo EPS, Kadir HBA, Kwek JL, Bee YM, et al. Non-Steroidal Anti-Inflammatory drugs and risk of acute kidney injury and hyperkalemia in older adults: A retrospective cohort study and external validation of a clinical risk model. Drugs & Aging; 2021;39:75\u201382.","DOI":"10.1007\/s40266-021-00907-w"},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"e001821","DOI":"10.1136\/bmjopen-2012-001821","volume":"2","author":"YJ Hwang","year":"2012","unstructured":"Hwang YJ, Shariff SZ, Gandhi S, Wald R, Clark E, Fleet JL, et al. Validity of the international classification of diseases, tenth revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission. BMJ Open. 2012;2:e001821.","journal-title":"BMJ Open"},{"key":"485_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/SLA.0b013e3181a40a0b","volume":"249","author":"A Bihorac","year":"2009","unstructured":"Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009;249:851\u20138.","journal-title":"Ann Surg"},{"key":"485_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2015.02.337","volume":"66","author":"ME Grams","year":"2015","unstructured":"Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, et al. A Meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66:591\u2013601.","journal-title":"Am J Kidney Dis"},{"key":"485_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1053\/j.ajkd.2015.02.338","volume":"66","author":"MT James","year":"2015","unstructured":"James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, et al. A Meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis. 2015;66:602\u201312.","journal-title":"Am J Kidney Dis"},{"key":"485_CR21","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","volume":"385","author":"RL Mehta","year":"2015","unstructured":"Mehta RL, Cerd\u00e1 J, Burdmann EA, Tonelli M, Garc\u00eda-Garc\u00eda G, Jha V, et al. International society of nephrology\u2019s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385:2616\u201343.","journal-title":"Lancet"},{"key":"485_CR22","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1053\/j.ajkd.2015.07.022","volume":"67","author":"ME Grams","year":"2016","unstructured":"Grams ME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, et al. Acute kidney injury after major surgery: A retrospective analysis of veterans health administration data. Am J Kidney Dis. 2016;67:872\u201380.","journal-title":"Am J Kidney Dis"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3949\/ccjm.85a.17009","volume":"85","author":"K Sharma","year":"2018","unstructured":"Sharma K, Slawski B. Renal disease and the surgical patient: minimizing the impact. Cleve Clin J Med. 2018;85:559\u201367.","journal-title":"Cleve Clin J Med"},{"key":"485_CR24","doi-asserted-by":"publisher","first-page":"e0226625","DOI":"10.1371\/journal.pone.0226625","volume":"14","author":"A El-Ahmadi","year":"2019","unstructured":"El-Ahmadi A, Abassi MS, Andersson HB, Engstr\u00f8m T, Clemmensen P, Helqvist S, et al. Acute kidney injury - A frequent and serious complication after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. PLoS ONE. 2019;14:e0226625.","journal-title":"PLoS ONE"},{"key":"485_CR25","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ekir.2022.01.1062","volume":"7","author":"C Ronsin","year":"2022","unstructured":"Ronsin C, Chaba A, Suchanek O, Coindre JP, Kerleau C, Garandeau C, et al. Incidence, risk factors and outcomes of kidney and liver cyst infection in kidney transplant recipient with ADPKD. Kidney Int Rep. 2022;7:867\u201375.","journal-title":"Kidney Int Rep"},{"key":"485_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajpath.2024.07.008","volume":"195","author":"T Yoshikawa","year":"2024","unstructured":"Yoshikawa T, Yanagita M. Single-Cell analysis provides new insights into the roles of tertiary lymphoid structures and immune cell infiltration in kidney injury and chronic kidney disease. Am J Pathol. 2024;195:40\u201354.","journal-title":"Am J Pathol"},{"key":"485_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10157-016-1334-0","volume":"20","author":"J Usui","year":"2016","unstructured":"Usui J, Yamagata K, Imai E, Okuyama H, Kajiyama H, Kanamori H, et al. Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version. Clin Exp Nephrol. 2016;20:827\u201331.","journal-title":"Clin Exp Nephrol"},{"key":"485_CR28","doi-asserted-by":"publisher","first-page":"e041543","DOI":"10.1136\/bmjopen-2020-041543","volume":"11","author":"K Ikuta","year":"2021","unstructured":"Ikuta K, Nakagawa S, Momo K, Yonezawa A, Itohara K, Sato Y, et al. Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case\u2013control study. BMJ Open. 2021;11:e041543.","journal-title":"BMJ Open"},{"key":"485_CR29","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373\u20139.","journal-title":"J Clin Epidemiol"},{"key":"485_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ki.2015.101","volume":"88","author":"T Dreischulte","year":"2015","unstructured":"Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88:396\u2013403.","journal-title":"Kidney Int"},{"key":"485_CR31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/pds.5621","volume":"32","author":"DM Calvo","year":"2023","unstructured":"Calvo DM, Saiz LC, Leache L, Celaya MC, Guti\u00e9rrez-Valencia M, Alonso A, et al. Effect of the combination of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: a nested case-control study. Pharmacoepidemiol Drug Saf. 2023;32:898\u2013909.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"485_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2288-8-48","volume":"8","author":"CJ Biesheuvel","year":"2008","unstructured":"Biesheuvel CJ, Vergouwe Y, Oudega R, Hoes AW, Grobbee DE, Moons KG. Advantages of the nested case-control design in diagnostic research. BMC Med Res Methodol. 2008;8:48.","journal-title":"BMC Med Res Methodol"},{"key":"485_CR33","volume-title":"Modern epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash T. Modern epidemiology. Third Edition: Lippincott Williams & Wilkins, Philadelphia;; 2008."},{"key":"485_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","volume":"133","author":"M Maclure","year":"1991","unstructured":"Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133:144\u201353.","journal-title":"Am J Epidemiol"},{"key":"485_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/oxfordjournals.aje.a117550","volume":"142","author":"MA Mittleman","year":"1995","unstructured":"Mittleman MA, Maclure M, Robins JM. Control sampling strategies for case-crossover studies: an assessment of relative efficiency. Am J Epidemiol. 1995;142:91\u20138.","journal-title":"Am J Epidemiol"},{"key":"485_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1373\/clinchem.2005.048595","volume":"51","author":"AW Rutjes","year":"2005","unstructured":"Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005;51:1335\u201341.","journal-title":"Clin Chem"},{"key":"485_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","volume":"18","author":"X Zhang","year":"2017","unstructured":"Zhang X, Donnan PT, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2017;18:256.","journal-title":"BMC Nephrol"},{"key":"485_CR38","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","volume":"76","author":"M Baker","year":"2020","unstructured":"Baker M, Perazella MA. NSAIDs in CKD: are they safe?? Am J Kidney Dis. 2020;76:546\u201357.","journal-title":"Am J Kidney Dis"},{"key":"485_CR39","doi-asserted-by":"publisher","first-page":"d3514","DOI":"10.1136\/bmj.d3514","volume":"342","author":"B Guthrie","year":"2011","unstructured":"Guthrie B, Mccowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;342:d3514.","journal-title":"BMJ"},{"key":"485_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000211713","volume":"79","author":"T Arakawa","year":"2009","unstructured":"Arakawa T, Fujiwara Y, Sollano JD, Zhu Q, Kachintorn U, Rani AA, et al. A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007. Digestion. 2009;79:177\u201385.","journal-title":"Digestion"},{"key":"485_CR41","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/1756-185X.13711","volume":"22","author":"R Sakai","year":"2019","unstructured":"Sakai R, Cho SK, Jang EJ, Harigai M, Sung YK. International descriptive study for comparison of treatment patterns in patients with knee osteoarthritis between Korea and Japan using claims data. Int J Rheum Dis. 2019;22:2052\u20138.","journal-title":"Int J Rheum Dis"},{"key":"485_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12891-021-04539-4","volume":"22","author":"Y Ritsuno","year":"2021","unstructured":"Ritsuno Y, Kawado M, Morita M, Yamada H, Kanaji A, Nakamura M, et al. Impact of musculoskeletal disorders on healthy life expectancy in Japan. BMC Musculoskelet Disord. 2021;22:661.","journal-title":"BMC Musculoskelet Disord"},{"key":"485_CR43","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1172\/JCI9956","volume":"106","author":"CM Hao","year":"2000","unstructured":"Hao CM, Yull F, Blackwell T, K\u00f6mhoff M, Davis LS, Breyer MD. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. J Clin Invest. 2000;106:973\u201382.","journal-title":"J Clin Invest"},{"key":"485_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1590\/2175-8239-jbn-2018-0107","volume":"41","author":"GNC Lucas","year":"2019","unstructured":"Lucas GNC, Leit\u00e3o ACC, Alencar RL, Xavier RMF, Daher EF, Silva Junior GBD. Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs. J Bras Nefrol. 2019;41:124\u201330.","journal-title":"J Bras Nefrol"},{"key":"485_CR45","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","volume":"64","author":"AK Muriithi","year":"2014","unstructured":"Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al. Biopsy-proven acute interstitial nephritis, 1993\u20132011: a case series. Am J Kidney Dis. 2014;64:558\u201366.","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-025-00485-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T06:04:55Z","timestamp":1757397895000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-025-00485-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1186\/s40780-025-00485-8","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Review Board of Shiga University of Medical Science (Approval Number: RRB20-014). The need for informed consent was waived because anonymized data provided by DeSC Healthcare Inc. were used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as the data we analyzed was anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TT received speakers from DAIICHI SANKYO COMPANY, LIMITED and CHUGAI PHARMACEUTICAL CO., Ltd. The Authors have no financial interests to declare. All the other authors have no financial interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}